
201 - 500 employees
🏥 Healthcare
🧬 Biotechnology
💊 Pharmaceuticals
💰 $300M Post-IPO Equity - Xenon Pharmaceuticals on 2023-11
Healthcare • Biotechnology • Pharmaceuticals
Xenon Pharmaceuticals Inc. is a clinical-stage biotechnology company focused on neuroscience drug discovery and development. It leverages human genetics, ion-channel biology, and novel chemistries to create selective modulators of central and peripheral nervous system ion channels. Its lead late-stage investigational candidate, azetukalner, is being developed for epilepsy and depression. The company emphasizes patient-centered research, clinical trials, and support for people affected by neurological and psychiatric disorders.
📡 We watch Xenon Pharmaceuticals Inc.'s careers page
Several times a day
how often we check
12
roles posted in the last 30 days
About 66 days
usual time to fill a role
7
roles closed in the last year
Selected: 🇺🇸 United States – Remote USA.
Selected: 🆕 Date Added.
🔥 14 hours ago
Director securing Medicaid and government payer coverage for Xenon’s neuroscience medicines. Leading formulary strategy, contracting, and patient access across U.S. government accounts.
🇺🇸 United States – Remote
💵 $236.7k - $260.2k / year
💰 $300M Post-IPO Equity - Xenon Pharmaceuticals on 2023-11
⏰ Full Time
🔴 Lead
👔 Director
👻 Ghost score 0%
🕒 November 2
Executive Business Director leading Xenon Pharmaceuticals' West epilepsy sales region. Building sales leadership teams and driving launch readiness for neuroscience therapeutics.
🇺🇸 United States – Remote
💵 $300k - $345k / year
💰 $300M Post-IPO Equity - Xenon Pharmaceuticals on 2023-11
⏰ Full Time
🔴 Lead
👔 Director
👻 Ghost score 0%
🕒 November 2
Executive Business Director leading Xenon's East-region epilepsy sales organization and launch readiness. Driving field performance, strategic accounts, and cross-functional execution for a neuroscience biopharmaceutical company.
🇺🇸 United States – Remote
💵 $300k - $345k / year
💰 $300M Post-IPO Equity - Xenon Pharmaceuticals on 2023-11
⏰ Full Time
🔴 Lead
👔 Director
👻 Ghost score 0%
🕒 October 21
Commercial director leading epilepsy KOL engagement, market intelligence, and launch readiness for Xenon Pharmaceuticals’ Azetukalner. Supporting cross-functional US commercial strategy across the Central region.
⛰️ Colorado, Illinois, +9 more states – Remote
💵 $245k - $270k / year
💰 $300M Post-IPO Equity - Xenon Pharmaceuticals on 2023-11
⏰ Full Time
🔴 Lead
👔 Director
👻 Ghost score 0%
🕒 July 13
National Account Director responsible for U.S. market access strategy and payer relationships at Xenon Pharmaceuticals. Collaborating across functions to ensure access to Azetukalner for epilepsy treatment.
🇺🇸 United States – Remote
💵 $236.7k - $260.2k / year
💰 $300M Post-IPO Equity - Xenon Pharmaceuticals on 2023-11
⏰ Full Time
🔴 Lead
🧑💼 Account Executive
👻 Ghost score 10%